Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer
Authors:
Open Access
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 14 (10) , 1505-1510
Abstract
Background: Endoglycosidic heparanase degrades heparan sulfate glycosaminoglycans, and may be important in cancer invasion and metastasis, although its expression in human cervical cancer has not been characterized. Materials and methods: Heparanase association with clinicopathological features related to prognostic significance was examined in patients presenting with invasive cervical cancer. Gene expression of heparanase was assessed by RT–PCR in 10 normal cervix and 92 invasive cervical cancer samples. Results: Heparanase mRNA expression was not detected in any of the normal cervix specimens, but was significantly higher in advanced-stage tumors (P = 0.026). In cases treated with radical hysterectomy and pelvic lymphadenectomy, heparanase mRNA expression was significantly higher in tumors exhibiting lymph-vascular space invasion (P = 0.01). A significant relationship was found between microvessel counts and heparanase mRNA expression (P = 0.035). The disease-free and overall survival rates of patients exhibiting heparanase mRNA expression were significantly lower than those of patients lacking heparanase mRNA expression (P = 0.019 and 0.017, respectively). Furthermore, multivariate analysis showed that heparanase mRNA expression was an independent prognostic factor for both disease-free and overall survival. Conclusions: These findings provide evidence that heparanase expression can serve as an indicator of aggressive potential and poor prognosis in cervical cancer. Consequently, heparanase inhibitor will be a novel candidate for therapeutic intervention in this disease.Keywords
This publication has 23 references indexed in Scilit:
- Human HeparanaseJournal of Biological Chemistry, 1999
- Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasisNature Medicine, 1999
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Substrate Specificity of Heparanases from Human Hepatoma and PlateletsJournal of Biological Chemistry, 1998
- Syndecans: multifunctional cell-surface co-receptorsBiochemical Journal, 1997
- Immunohistochemical localization of syndecan‐1 in normal and pathological human uterine cervixThe Journal of Pathology, 1994
- Cell surface heparan sulfate proteoglycans.Journal of Biological Chemistry, 1992
- Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.Proceedings of the National Academy of Sciences, 1992
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Structure and biological activity of basement membrane proteinsEuropean Journal of Biochemistry, 1989